Loading…
TCPL Packaging Ltd
NSE: TCPLPACK BSE: 523301 INE822C01015 Industrials Industrial Products 🔎 Screen
₹2,346 Cr
Market Cap
20.5
P/E
0.88
PEG
20.0%
ROCE
23.8%
ROE
0.97
D/E
16.0%
OPM
⚖️ Compare? 🔒 Generate Report 📚 Guides
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
Shareholding
About

Incorporated in 1987, TCPL Packaging Ltd manufactures paperboard-based packaging materials and flexible packaging products

✓ Strengths 1
  • Company has been maintaining a healthy dividend payout of 20.8%
! Concerns

No concerns data yet.

Key Ratios Snapshot
📊 Sector Averages
📈 Growth Pattern
📊 Quick Scorecard
Loading…
🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
Mixed quarter: revenue grew 9.2% YoY and EBITDA margin held near 17.4%, but PAT plunged 42.9% due to exceptional items, higher tax, and depreciation; export markets were subdued. quarter Investor Presentation One-Pager? Mar 2026
Revenue
₹465.2 Cr
+9.2% YoY (consolidated total income)
EBITDA Margin
17.4%
Down 42 bps YoY; raw material cost pressure
PAT
₹21.7 Cr
Down 42.9% YoY; hit by exceptional items of ₹2.22 Cr
Cash PAT
₹60.8 Cr
Up 5.0% YoY; depreciation up 11.8%
What Went Right
  • Consolidated total income rose 9.2% YoY to ₹465.2 Cr, driven by resilient domestic demand.
  • Flexible packaging business delivered strong capacity utilisation across plants; last commissioned line operating optimally.
  • Chennai Greenfield paperboard facility scaling up with encouraging customer traction.
  • EcoVadis Bronze Medal in debut assessment (top 35% globally) and UNGC commitment strengthen ESG positioning.
  • Cash profit grew 5.0% YoY to ₹60.8 Cr, supported by stable EBITDA generation.
What to Watch
  • PAT crashed 42.9% YoY to ₹21.7 Cr due to a ₹2.22 Cr exceptional item and a jump in tax expense (₹18.5 Cr vs ₹1.5 Cr in Q4 FY25).
  • EBITDA margin contracted 42 bps to 17.4% as raw material costs rose 14% YoY and pricing pass-through lagged.
  • Exports were impacted by geopolitical disruptions in the Middle East, weighing on overall revenue mix.
  • FY26 PAT fell 31.6% to ₹97.8 Cr; full-year finance costs surged 36.2% to ₹79.4 Cr, eroding profitability.
  • Exceptional items for FY26 totalled ₹13.79 Cr, a large drag on reported net income.
Investor Lens
This quarter exposed the gap between revenue growth and earnings quality. Despite a 9.2% revenue increase, PAT collapsed 42.9% because of exceptional items, higher taxes, and a 14% spike in raw material costs that squeezed margins 42 bps. The company acknowledges the cost pass-through lag and is banking on calibrated pricing actions and product mix improvements to restore margins. The 36.2% full-year finance cost jump is a concern, though net debt of ₹554.7 Cr against net worth of ₹1,293.5 Cr keeps leverage manageable. The export headwind from Middle East disruptions is temporary, with management expecting normalisation. The domestic volume story remains intact, and ESG credentials are improving, but near-term profitability will depend on how quickly costs are recovered and whether the exceptional charges recur. Next quarter's margin trajectory and export momentum will be critical to watch.
From investor presentation · AI-generated analysis · Not investment advice
🔒
Premium Feature
Investor Presentation One-Pager — quarterly highlights, what went right/wrong & management guidance
Upgrade to Premium
Already a member? Log in
📉 WEAK Net profit drops 40% YoY, OPM falls to 15% despite revenue growth.
Revenue
Revenue for Mar 2026 quarter stood at ₹436.0 Cr, up 6.3% YoY from ₹410 Cr but down 3.8% QoQ from ₹453 Cr. The growth is moderate but sequential decline suggests demand softness.
Profitability
Net profit fell sharply by 40% YoY to ₹21.0 Cr (vs ₹35 Cr) and 16% QoQ. EPS dropped from ₹38.79 to ₹23.26. High effective tax rate of 47% further compressed bottom line.
Margins
Operating profit margin contracted to 15% from 17% a year ago and prior quarter, indicating cost pressures or pricing headwinds. Operating profit fell 4.3% YoY despite revenue growth.
Cash Flow
Cash flow data not provided in the results.
Balance Sheet
Total borrowings stand at ₹599 Cr with reserves of ₹711 Cr, resulting in a debt-to-equity ratio of 0.97, which is elevated. Total assets of ₹1,657 Cr reflect a leveraged capital structure.
Key Risks
High leverage (D/E 0.97) and falling profitability increase financial risk. The sharp 40% PAT decline and margin compression signal operational stress. Elevated tax rate of 47% may persist.
Outlook
Given weakening margins and rising debt, near-term earnings may remain under pressure unless revenue momentum improves significantly. Cost control and debt reduction will be critical for recovery.
Generated by AI · Mar 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock AI Advisor.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Documents.

Access concall transcripts, annual reports, credit ratings, and investor presentations.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including equities and mutual funds, involves inherent risks, including the potential loss of principal. All investments are subject to market fluctuations, regulatory changes, and other risks that may affect their value. Past performance is not indicative of future results. This report is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This report does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a SEBI-registered investment adviser or other qualified financial professional before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities or financial instruments discussed in this report. Any such positions, if material, are disclosed to the best of the author's knowledge and are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company, institution, or third party.

Information Sources:
The analysis and opinions expressed herein are based on publicly available information, including but not limited to company filings with the BSE/NSE, annual reports, management commentary, investor presentations, data from the Reserve Bank of India (RBI), SEBI, industry publications, and other reliable financial data sources. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This report may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. The author does not undertake any obligation to update such statements in the future.

Regulatory Compliance:
This report is intended to comply with the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, as amended, and other applicable Indian laws and regulations.

Limitation of Liability:
The content of this report is provided "as is" without any warranties, express or implied, including accuracy, completeness, merchantability, or fitness for a particular purpose. The author and publisher expressly disclaim any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.